VEGFD and carcinoma: Independent of the tumor stage, about 40 % of the carcinomas had a positive capillary and small vessel-related VEGF-D immunoreactivity and 40–60 % had a large vessel-related VEGF-D immunopositivity in the tumor center (Fig. 2).